- $7.89bn
- $8.28bn
- $1.44bn
Brief: Azek Company Q1 Adjusted EPS USD 0.17 Vs. IBES Estimate USD 0.13
Brief: The AZEK Company Announces Chief Financial Officer Transition
U.S. RESEARCH ROUNDUP- Apellis Pharmaceuticals, Energizer Holdings, Walmart
Brief: The Azek Company Announces Fourth Quarter And Full-Year Fiscal 2024 Results
Azek Company Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Azek Company Q4 Adjusted EPS USD 0.29 Vs. IBES Estimate USD 0.27
Brief: The Azek Company Announces Strategic Distribution Partnership With Capital Lumber
Brief: Rakesh Mohan Joins The Azek Company As Chief Digital & Technology Officer
Barclays says US building products and homebuilders face a lackluster season
Brief: The Azek Company Announces ABL And Term Loan Refinancing
U.S. RESEARCH ROUNDUP- Apollo, Blackstone, Hershey
U.S. RESEARCH ROUNDUP-Amphastar Pharmaceuticals, Guardant Health, Upwork
Azek Company Inc reports results for the quarter ended in January - Earnings Summary
Brief: Azek Company Q3 Adjusted EPS USD 0.42 Vs. IBES Estimate USD 0.36
Azek Company Inc expected to post earnings of 36 cents a share - Earnings Preview
Brief: The Azek Company Announces $50 Million Accelerated Share Repurchase Program
Brief: The Azek Company Announces $600 Million Share Repurchase Program
Brief: Azek Receives NYSE Notice Regarding Filing Of Form 10-Q
Brief: Azek Company Q2 Sales USD 418.408 Million Vs. IBES Estimate USD 412.7 Million